Operating Cash Flow Turns Negative, with a Decline in Cash and Cash Equivalents
First written in FY2022-Q2. 6 of 10 entries say "Mitigated", first in FY2023-Q2. Latest entry: FY2027-H1.
2 other companies' latest entry also says "Restated".
- FY2027-H1RestatedAnnual report
「Funds generated from operating activities amounted to ¥1,244 million, compared with ¥1,907 million generated in the previous interim consolidated accounting period.」
Although cash flow from operating activities declined from the year-earlier period, the company generated ¥1,244 million, while cash and cash equivalents increased by ¥1,072 million from the fiscal year-end. - FY2026MitigatedAnnual report
「Funds provided by operating activities amounted to ¥2,228 million, compared with ¥484 million provided in the previous year.」
Operating cash flow increased from ¥484 million provided in the previous year to ¥2,228 million provided, and operating cash flow and cash balances improved. - FY2026-H1MitigatedAnnual report
「Funds provided by operating activities amounted to ¥1,907 million, compared with ¥1,149 million provided in the previous interim consolidated accounting period.」
Operating cash flow increased from ¥1,149 million in the same period of the previous year to ¥1,907 million, while cash and cash equivalents also increased by ¥1,024 million from the period-end. - FY2025MitigatedAnnual report
「Funds provided by operating activities amounted to ¥484 million, compared with ¥622 million used in the same period of the previous year.」
Operating cash flow shifted from ¥622 million used in the previous year to ¥484 million provided, eliminating the operating cash flow deficit. - FY2025-H1MitigatedAnnual report
「Funds provided by operating activities amounted to ¥1,149 million, compared with ¥791 million provided in the previous interim consolidated accounting period.」
Operating cash flow increased from ¥791 million in the same period of the previous year to ¥1,149 million, while cash and cash equivalents also increased by ¥911 million from the previous fiscal year-end. This represents an improvement from the operating cash flow deficit recorded in the previous full fiscal year. - FY2024WorsenedAnnual report
「Funds used in operating activities amounted to ¥622 million, compared with ¥161 million provided in the same period of the previous year.」
Operating cash flow shifted from ¥161 million provided in the previous year to ¥622 million used, while cash and cash equivalents also decreased by ¥418 million. - FY2024-Q2MitigatedAnnual report
「Funds provided by operating activities amounted to ¥791 million, compared with ¥493 million provided in the same quarter of the previous year.」
Operating cash flow increased from ¥493 million provided in the same period of the previous year to ¥791 million provided, while cash and cash equivalents also increased by ¥714 million from the previous consolidated fiscal year-end. - FY2023-Q2MitigatedAnnual report
「Funds provided by operating activities amounted to ¥493 million, compared with ¥641 million used in the same quarter of the previous year.」
Operating cash flow shifted from ¥641 million used in the same period of the previous year to ¥493 million provided. Cash and cash equivalents also increased by ¥28 million from the previous consolidated fiscal year-end. - FY2022WorsenedAnnual report
「Funds used in operating activities amounted to ¥794 million, compared with ¥633 million provided in the same period of the previous year.」
Operating cash flow deteriorated from ¥633 million provided in the previous year to ¥794 million used, while cash and cash equivalents also decreased by ¥944 million. - FY2022-Q2First statedAnnual report
「Cash and cash equivalents (hereinafter, "funds") during the cumulative second quarter of the current consolidated fiscal year decreased by ¥835 million from the previous consolidated fiscal year-end to ¥2,328 million. Funds used in operating activities amounted to ¥641 million, compared with ¥795 million provided in the same quarter of the previous year.」
Operating cash flow shifted from ¥795 million provided in the same period of the previous year to ¥641 million used, while cash and cash equivalents also decreased by ¥835 million from the previous consolidated fiscal year-end.